James L. Tyree, Director at ChemoCentryx, Inc. (CCXI), sold 10,000 shares at $50.22 ($502K) on 2022-08-04, disclosed to the SEC on 2022-08-08.
Open-market sale of $502k CCXI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |